These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3418 related articles for article (PubMed ID: 6681771)

  • 1. Activity of camptothecin, harringtonin, cantharidin and curcumae in the human tumor stem cell assay.
    Jiang TL; Salmon SE; Liu RM
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):263-70. PubMed ID: 6681771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cells.
    Jiang TL; Liu RH; Salmon SE
    Invest New Drugs; 1983; 1(1):21-5. PubMed ID: 6678854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptinium.
    Umbach GE; Hug V; Spitzer G; Thames H; Drewinko B
    Invest New Drugs; 1984; 2(3):263-5. PubMed ID: 6210262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytotoxicity of hydroxycamptothecin and four other antineoplastic agents on KB cells].
    Wang XW; Yu WJ; Shen ZM; Yang JL; Xu B
    Zhongguo Yao Li Xue Bao; 1987 Jan; 8(1):86-90. PubMed ID: 2955666
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay.
    Ludwig R; Alberts DS; Miller TP; Salmon SE
    Cancer Chemother Pharmacol; 1984; 12(3):135-41. PubMed ID: 6705130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antitumor activity of 9-nitro-camptothecin as a single agent and in combination with other antitumor drugs.
    Bernacki RJ; Pera P; Gambacorta P; Brun Y; Greco WR
    Ann N Y Acad Sci; 2000; 922():293-7. PubMed ID: 11193904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of topotecan, a new topoisomerase I inhibitor, against human tumor colony-forming units in vitro.
    Burris HA; Hanauske AR; Johnson RK; Marshall MH; Kuhn JG; Hilsenbeck SG; Von Hoff DD
    J Natl Cancer Inst; 1992 Dec; 84(23):1816-20. PubMed ID: 1331485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of drug sensitivity on human colon adenocarcinoma cells grown in soft agar and in athymic mice.
    Zirvi KA; Masui H; Giuliani FC; Kaplan NO
    Int J Cancer; 1983 Jul; 32(1):45-51. PubMed ID: 6862693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative studies of pulse and continuous exposure in human tumor clonogenic assay.
    Kanzawa F; Matsushima Y; Chiang CD; Nakano H; Nakagawa K; Takahashi H; Sasaki Y; Saijo N
    J Pharmacobiodyn; 1987 Sep; 10(9):449-51. PubMed ID: 3437386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor activity of vinzolidine in the human tumor clonogenic assay and comparison with vinblastine.
    Takasugi BJ; Salmon SE; Nelson RL; Young L; Liu RM
    Invest New Drugs; 1984; 2(1):49-53. PubMed ID: 6469498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor activity of didemnin B in the human tumor stem cell assay.
    Jiang TL; Liu RH; Salmon SE
    Cancer Chemother Pharmacol; 1983; 11(1):1-4. PubMed ID: 6883622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cloned human leukocyte interferons in the human tumor stem cell assay.
    Salmon SE; Durie BG; Young L; Liu RM; Trown PW; Stebbing N
    J Clin Oncol; 1983 Mar; 1(3):217-25. PubMed ID: 6686847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A murine model to evaluate the ability of in vitro clonogenic assays to predict the response to tumors in vivo.
    Mirabelli CK; Sung CM; McCabe FL; Faucette LF; Crooke ST; Johnson RK
    Cancer Res; 1988 Oct; 48(19):5447-54. PubMed ID: 3046738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative study of antitumor activity of cantharidin and cantharis peptides].
    Liao XY; Lu SG; Feng JF
    Zhong Yao Cai; 2013 Oct; 36(10):1566-9. PubMed ID: 24761662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor activity of esorubicin in human tumor clonogenic assay with comparisons to doxorubicin.
    Salmon SE; Young L; Soehnlen B; Liu R
    J Clin Oncol; 1984 Apr; 2(4):282-6. PubMed ID: 6707716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assay.
    Salmon SE; Meyskens FL; Alberts DS; Soehnlen B; Young L
    Cancer Treat Rep; 1981; 65(1-2):1-12. PubMed ID: 7226159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of harringtonine and homoharringtonine on the colony-forming efficiency of tumor cells in vitro].
    Xu CX; Han R; Guo ZR; Wang DF; Zhang JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1987 Feb; 9(1):18-22. PubMed ID: 2954685
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of homoharringtonine on proliferation and differentiation of human leukemic cells in vitro.
    Zhou JY; Chen DL; Shen ZS; Koeffler HP
    Cancer Res; 1990 Apr; 50(7):2031-5. PubMed ID: 2317793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of human leukocyte interferon with vinca alkaloids and other chemotherapeutic agents against human tumors in clonogenic assay.
    Aapro MS; Alberts DS; Salmon SE
    Cancer Chemother Pharmacol; 1983; 10(3):161-6. PubMed ID: 6861260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cantharidins on leukemic stem cells.
    Dorn DC; Kou CA; Png KJ; Moore MA
    Int J Cancer; 2009 May; 124(9):2186-99. PubMed ID: 19123473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 171.